SCHEMBL26419959

SCHEMBL26419959

CNC(=O)c1cn(CC(C)(C)F)nc1C(F)F

nearest known ligand 0.43

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KLKB1 P03952 6/20 0.43
GAA P10253 1/20 0.33
GLS O94925 4/20 0.32
MAP2K2 P36507 1/20 0.32
MAP2K1 Q02750 1/20 0.32
LMNA P02545 1/20 0.32
POLB P06746 1/20 0.32
METAP2 P50579 1/20 0.32
IRAK4 Q9NWZ3 2/20 0.31
ALDH1A1 P00352 2/20 0.31
ADORA3 P0DMS8 1/20 0.31
ADORA2A P29274 1/20 0.31
ADORA1 P30542 1/20 0.31
KDM4E B2RXH2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26135704 0.83 ADORA3 (0.36) KLKB1IRAK4ADORA3
SCHEMBL12092481 0.78 GAA (0.43) KLKB1GAAMAP2K2MAP2K1LMNA
SCHEMBL26388999 0.73
SCHEMBL26135903 0.72 ADORA3 (0.36) KLKB1ADORA3
SCHEMBL26420142 0.70 LMNA (0.39) KLKB1LMNAPOLBALDH1A1ADORA3
SCHEMBL26406187 0.70 ADORA3 (0.41) KLKB1LMNAALDH1A1ADORA3ADORA2A
SCHEMBL12057438 0.69 POLB (0.42) KLKB1LMNAPOLBIRAK4
SCHEMBL26406052 0.67 ADORA3 (0.38) KLKB1LMNAALDH1A1ADORA3ADORA2A
SCHEMBL18330041 0.66 KLKB1 (0.39) KLKB1GAALMNAPOLBALDH1A1
SCHEMBL1871681 0.66 L3MBTL1 (0.40) KLKB1GAALMNAALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023192901-A9 QUINOLINE DERIVATIVES AS MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X2 AND RELATED PRODUCTS ESCIENT PHARMACEUTICALS, INC. (US) 2023-12-14 WO disclosed
WO-2023192901-A1 QUINOLINE DERIVATIVES AS MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X2 AND RELATED PRODUCTS ESCIENT PHARMACEUTICALS, INC. (US) 2023-10-05 WO disclosed